Yet BPC-157, short for Body Protection Compound-157, has accumulated a striking body of preclinical evidence suggesting it accelerates tendon healing, repairs intestinal injury, modulates the nervous system, and does so without the toxicity profile that complicates many pharmacological interventions
PubMed Central , Drug Testing and Analysis , vol
Pharm Basel Switz
(wada-ama.org) The clinical bottom line (Meto-style) AOD-9604 is a legitimate fat-metabolism peptide in the sense that it has: a plausible mechanism, preclinical support, and a history of controlled human trials
For individuals with underlying conditions that contribute to B12 deficiency, such as pernicious anemia or gastrointestinal disorders, follow-up care may involve managing these conditions to optimize B12 absorption